Yanhua Xu

机构：Nanjing Tech University, China National Pharmaceutical Group Corporation (China), Shanghai Institute of Process Automation Instrumentation (China) · ORCID：0000-0001-5948-5258

发表论文 90 篇 · 总被引 5313 次 · h-index 26

代表论文

• A Mn Al double adjuvant nanovaccine to induce strong humoral and cellular immune responses (2023 · Journal of Controlled Release · 被引 43)
• Emerging advances in delivery systems for mRNA cancer vaccines (2024 · Journal of Controlled Release · 被引 31)
• Triple functional mild photothermal improves gene editing of PD-L1 for enhanced antitumor immunity (2023 · Journal of Controlled Release · 被引 28)
• Rectifying the Crosstalk between the Skeletal and Immune Systems Improves Osteoporosis Treatment by Core–Shell Nanocapsules (2025 · ACS Nano · 被引 19)
• Transdermal Microneedles Alleviated Rheumatoid Arthritis by Inducing Immune Tolerance via Skin‐Resident Antigen Presenting Cells (2023 · Small · 被引 19)
• Antigens and adjuvants co-stabilized Pickering emulsions amplify immune responses of subunit vaccines (2025 · Journal of Controlled Release · 被引 18)